Cheng Jiang, PhD

    • 3601 Citations
    • 35 h-Index
    1992 …2019
    If you made any changes in Pure, your changes will be visible here soon.

    Personal profile

    Research interests

    Dr. Cheng Jiang's research is focused on the cellular and molecular signaling mechanisms relevant to prostate and breast cancer chemoprevention.

    Many of her publications deal with identification of herbal chemicals and novel selenium compounds targeting sex hormone signaling related to breast and prostate cancer.

    Dr. Jiang has profound bilateral hearing loss and prefers email communications from her collaborators.

    Fingerprint Dive into the research topics where Cheng Jiang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

    • 9 Similar Profiles
    Prostatic Neoplasms Medicine & Life Sciences
    Selenium Medicine & Life Sciences
    Apoptosis Medicine & Life Sciences
    Angelica Medicine & Life Sciences
    Pyranocoumarins Medicine & Life Sciences
    Selenious Acid Medicine & Life Sciences
    Neoplasms Medicine & Life Sciences
    Androgen Receptors Medicine & Life Sciences

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output 1992 2019

    • 3601 Citations
    • 35 h-Index
    • 60 Article
    • 7 Review article
    • 2 Chapter
    • 1 Comment/debate

    Optimizing live-animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID-NSG mice

    Kim, S., Zhang, Y., Tang, S., Qin, C., Karelia, D., Sharma, A., Jiang, C. & Lu, J., Jun 15 2019, In : Prostate. 79, 9, p. 949-960 12 p.

    Research output: Contribution to journalArticle

    SCID Mice
    Tumor Burden
    Luciferases
    Heterografts
    Prostatic Neoplasms
    3 Citations (Scopus)
    Androgen Receptors
    Reactive Oxygen Species
    Prostatic Neoplasms
    Apoptosis
    Prostate-Specific Antigen
    3 Citations (Scopus)

    Role of p53-senescence induction in suppression of LNCaP prostate cancer growth by cardiotonic compound bufalin

    Zhang, Y., Dong, Y., Melkus, M. W., Yin, S., Tang, S. N., Jiang, P., Pramanik, K., Wu, W., Kim, S., Ye, M., Hu, H., Lu, J. & Jiang, C., Nov 1 2018, In : Molecular cancer therapeutics. 17, 11, p. 2341-2352 12 p.

    Research output: Contribution to journalArticle

    Cardiotonic Agents
    Prostatic Neoplasms
    Growth
    Androgen Receptors
    Caspases
    1 Citation (Scopus)

    Prostate Cancer Xenograft Inhibitory Activity and Pharmacokinetics of Decursinol, a Metabolite of Angelica gigas Pyranocoumarins, in Mouse Models

    Wu, W., Tang, S. N., Zhang, Y., Puppala, M., Cooper, T. K., Xing, C., Jiang, C. & Lu, J., Jan 1 2017, In : American Journal of Chinese Medicine. 45, 8, p. 1773-1792 20 p.

    Research output: Contribution to journalArticle

    Pyranocoumarins
    Angelica
    Heterografts
    Prostatic Neoplasms
    Pharmacokinetics
    25 Citations (Scopus)

    Cancer chemoprevention research with selenium in the post-SELECT era: Promises and challenges

    Lu, J., Zhang, J., Jiang, C., Deng, Y., Özten, N. & Bosland, M. C., Jan 2 2016, In : Nutrition and cancer. 68, 1, p. 1-17 17 p.

    Research output: Contribution to journalReview article

    Selenomethionine
    Chemoprevention
    Selenium
    Yeasts
    Research